Ran Frenkel
Corporate Officer/Principal presso 2P2D Solutions Ltd.
Patrimonio netto: 164 566 $ in data 31/03/2024
Profilo
Ran Frenkel is the founder of Pfc Pharma Focus Israel Ltd.
which was founded in 2007.
He is currently the Vice President-Business Development at 2P2D Solutions Ltd.
Mr. Frenkel's former positions include Managing Director-EMEA at Clinipace, Inc. from 2011 to 2013, Managing Director at Actelion Pharmaceuticals US, Inc. from 2004 to 2007, and Executive VP-Worldwide Development Operations at Karyopharm Therapeutics, Inc. from 2014 to 2015.
Mr. Frenkel received his undergraduate degree from The Hebrew University of Jerusalem in 1993.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 20/03/2023 | 108 984 ( 0.09% ) | 164 566 $ | 31/03/2024 |
Posizioni attive di Ran Frenkel
| Società | Posizione | Inizio |
|---|---|---|
2P2D Solutions Ltd.
 2P2D Solutions Ltd. Medical SpecialtiesHealth Technology 2P2D Solutions Ltd. develops an automated drug monitoring system. Its products include ClinicAid and SlimPack. The company was founded by Ofer Baram and Mordechai Peer in 2007 and is headquartered in Tel Aviv, Israel. | Corporate Officer/Principal | 08/03/2011 |
Precedenti posizioni note di Ran Frenkel
| Società | Posizione | Fine |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | 27/07/2022 |
Clinipace, Inc.
 Clinipace, Inc. Miscellaneous Commercial ServicesCommercial Services Clinipace, Inc. provides digital contract research solutions. The firm operates as a digital contract research organization that assists life science firms in developing and executing regulatory strategies, clinical development, and post-approval research. Its service areas encompass clinical monitoring, data management, medical affairs and writing, patient recruitment, study feasibility, and site selection and management. The company was founded by Ronald G. Marks, Christopher K. Porter, and Jeff Lewis Williams in 2003 and is headquartered in Morrisville, NC. | Corporate Officer/Principal | 01/01/2013 |
| Pfc Pharma Focus Israel Ltd. | Founder | 01/01/2011 |
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Corporate Officer/Principal | 01/01/2007 |
Formazione di Ran Frenkel
| The Hebrew University of Jerusalem | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Clinipace, Inc.
Clinipace, Inc. Miscellaneous Commercial ServicesCommercial Services Clinipace, Inc. provides digital contract research solutions. The firm operates as a digital contract research organization that assists life science firms in developing and executing regulatory strategies, clinical development, and post-approval research. Its service areas encompass clinical monitoring, data management, medical affairs and writing, patient recruitment, study feasibility, and site selection and management. The company was founded by Ronald G. Marks, Christopher K. Porter, and Jeff Lewis Williams in 2003 and is headquartered in Morrisville, NC. | Commercial Services |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Health Technology |
2P2D Solutions Ltd.
2P2D Solutions Ltd. Medical SpecialtiesHealth Technology 2P2D Solutions Ltd. develops an automated drug monitoring system. Its products include ClinicAid and SlimPack. The company was founded by Ofer Baram and Mordechai Peer in 2007 and is headquartered in Tel Aviv, Israel. | Health Technology |
| Pfc Pharma Focus Israel Ltd. |
- Borsa valori
- Insiders
- Ran Frenkel
